Sharemaestro company-news research for OncoSil Medical Limited (OSL), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
ASX
Australia
Provisional evidence
Company news sentiment
OSL news sentiment
OncoSil Medical Limited
Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.
30-day score50Neutral is 50
Early balanced news score
15/100 evidence confidence
100% direct company focus
9 current stories across 6 publishers
Current company news
Early balanced news score
9 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.
Observed headline tone50/100
→
Reliability-adjusted score50/100
Latest source headline
Top Healthcare Stocks to Watch: Why Is OncoSil Medical (ASX:OSL) in Focus?
Kalkine Media · 07 Aug 2026 07:21 · Source lookup
Freshness, source quality and evidence depth temper uncertain readings toward 50; confidence remains a separate reliability measure.
What supports the score
9 current stories are mapped specifically to OSL.
The read spans 6 publishers rather than depending on one outlet.
What limits the score
The stories agree, but freshness-weighted evidence is only 0.014.
Evidence confidence is 15/100, below the threshold for a firm classification.
50/100
News scoreEarly balanced news score
15/100
Confidencethin evidence
100%/100
Company news9 company stories
100/100
Story agreement0/100 difference
News history
Daily score and story count over 30 days
15 Jul30 Jul13 Aug
News scoreStory count50 baseline
Confidence
How reliable the score is
Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.
Amount of evidence0
0.014 after freshness weightingSource breadth100
6 independent publishersCompany relevance100
share tied directly to this companyFreshness15
recency-weighted evidenceAgreement100
how closely stories agreePublisher mix64
less reliance on one publisherPrice and news history
News score and weekly price over 26 weeks
Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
WeekNews scoreCloseWeekly move
07 Aug 202650AUD 1.25+7.3%
31 Jul 202650AUD 1.16-3.7%
24 Jul 202650AUD 1.21-16.9%
17 Jul 202650AUD 1.45+9.8%
10 Jul 202650AUD 1.32+34.0%
03 Jul 202650AUD 0.98+45.9%
26 Jun 202650AUD 0.68-15.1%
Provisional evidence
News subjects
What is shaping the score
Market update506 stories · 67%
Earnings503 stories · 33%
Source mix
Where the evidence comes from
Ad-hoc-news.de502 stories · 22%
ad-hoc-news.de502 stories · 22%
Kalkine Media501 stories · 11%
Kalkine501 stories · 11%
Stockhead501 stories · 11%
Market Index501 stories · 11%
Market source501 stories · 11%
Recurring subjects
Subjects appearing most often
Topic structure will appear when classified tags are present in the current feed.
Earlier readings
How the score has changed
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
22 Jun50 neutral13 Aug 14:43
ConstructiveBalanced or withheldCautious
Changes in the stored score
Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.
| Observed | Score | Move | Confidence | Stories | Status |
|---|---|---|---|---|---|
| 13 Aug 14:43 | 50 | +0 | 15/100 (-7) | 9 (-1) | Provisional |
| 07 Aug 23:59 | 50 | +0 | 22/100 (0) | 10 (0) | Provisional |
| 01 Aug 23:59 | 50 | +0 | 22/100 (0) | 10 (+1) | Provisional |
| 31 Jul 23:59 | 50 | +0 | 22/100 (-5) | 9 (-4) | Provisional |
| 23 Jul 23:59 | 50 | +0 | 27/100 (+1) | 13 (+1) | Provisional |
| 22 Jul 23:59 | 50 | +0 | 26/100 (0) | 12 (-1) | Provisional |
| 20 Jul 23:59 | 50 | +0 | 26/100 (0) | 13 (+1) | Provisional |
| 19 Jul 23:59 | 50 | +0 | 26/100 (0) | 12 (+1) | Provisional |
Source headlines
The news behind the score
Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.
#150Tone
Kalkine MediaDirect company coverageScored from headlineSource lookup
Top Healthcare Stocks to Watch: Why Is OncoSil Medical (ASX:OSL) in Focus?
- Published
- 07 Aug 2026 07:21
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- High · 38.8% · 6.3d old
- Duplicates
- 1 consolidated
#250Tone
KalkineDirect company coverageScored from headlineSource lookup
OncoSil Medical (ASX:OSL): An 'Overnight Success' Decades in the Making as Manufacturing and FDA Decision Loom
- Published
- 01 Aug 2026 00:12
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- Low · 4.4% · 12.6d old
- Duplicates
- 2 consolidated
#350Tone
StockheadDirect company coverageScored from headlineSource lookup
Dr Boreham’s Crucible: OncoSil emerging as an overnight success after decades
- Published
- 31 Jul 2026 03:59
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- Low · 3.3% · 13.4d old
- Duplicates
- 1 consolidated
#450Tone
Ad-hoc-news.deDirect company coverageScored from headlineSource lookup
Abbott stock trades steady as diagnostics and medical devices underpin earnings momentum
- Published
- 23 Jul 2026 06:05
- News subject
- Earnings
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- High · 27.5% · 21.4d old
- Duplicates
- 1 consolidated
#550Tone
Ad-hoc-news.deDirect company coverageScored from headlineSource lookup
Abbott Laboratories stock steadies as medical devices and diagnostics underpin growth
- Published
- 22 Jul 2026 23:43
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- Low · 0.2% · 21.6d old
- Duplicates
- 1 consolidated
#650Tone
ad-hoc-news.deDirect company coverageScored from headlineSource lookup
Abbott Laboratories stock trades steady as diagnostics and medical devices support growth
- Published
- 20 Jul 2026 14:26
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 24.0d old
- Duplicates
- 1 consolidated
#750Tone
ad-hoc-news.deDirect company coverageScored from headlineSource lookup
Abbott Laboratories stock holds firm as diagnostics and medical devices support earnings
- Published
- 19 Jul 2026 18:21
- News subject
- Earnings
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- Medium · 16.9% · 24.8d old
- Duplicates
- 1 consolidated
#850Tone
Market IndexDirect company coverageScored from headlineSource lookup
ChartWatch ASX Scans: Telstra, TPG Telecom, Xero, Macquarie, AMP, Metcash, Oncosil Medical, Pexa
- Published
- 16 Jul 2026 19:30
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 27.8d old
- Duplicates
- 1 consolidated
#950Tone
Market sourceDirect company coverageScored from headlineSource lookup
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Published
- 15 Jul 2026 17:09
- News subject
- Earnings
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- Medium · 8.9% · 28.9d old
- Duplicates
- 1 consolidated
Earlier company news
OSL news archive
Stored newest first for historical research. These older headlines are retained for reference and do not contribute to the current sentiment gauge above. Where an early legacy import did not retain its canonical URL, the headline links to an exact publisher-aware source lookup instead of inventing an article address.
Jul
29
2026
KalkineArchivedLegacy headline · tone unscoredLegacy source lookup
OncoSil Medical (ASX: OSL): FDA Decision Nears
- Published
- 29 Jul 2026 19:12
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
09
2026
TradingViewArchivedLegacy headline · tone unscoredLegacy source lookup
Enterprise value to revenue forward of OncoSil Medical Ltd Warrant 2026-30.06.27 OncoSil Medical – ASX:OSLOE
- Published
- 9 Jul 2026 07:16
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
03
2026
Kalkine MediaArchivedLegacy headline · tone unscoredLegacy source lookup
Could OncoSil Medical (ASX:OSL) Be Nearing Its Biggest Regulatory Milestone Yet?
- Published
- 3 Jul 2026 06:19
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
01
2026
KalkineArchivedLegacy headline · tone unscoredLegacy source lookup
OncoSil Medical (ASX:OSL) Share Price Holds Steady as Investors Monitor MedTech Sector
- Published
- 1 Jul 2026 04:59
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
30
2026
AD HOC NEWSArchivedLegacy headline · tone unscoredLegacy source lookup
Select Medical Holdings earnings calendar sets up the SEM shares, healthcare stock on NYSE draws ana
- Published
- 30 Jun 2026 07:26
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
28
2026
TradingViewArchivedLegacy headline · tone unscoredLegacy source lookup
Price to earnings forward of OncoSil Medical Ltd – ASX:OSL
- Published
- 28 Jun 2026 08:13
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
27
2026
KalkineArchivedLegacy headline · tone unscoredLegacy source lookup
Biotech Back in Play? Why OncoSil Medical (ASX: OSL) Is Turning Heads on the ASX
- Published
- 27 Jun 2026 14:44
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
27
2026
KalkineArchivedLegacy headline · tone unscoredLegacy source lookup
OncoSil Medical (ASX:OSL) Spikes as Biotech Traders Eye a Turnaround
- Published
- 27 Jun 2026 08:40
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
22
2026
KalkineArchivedLegacy headline · tone unscoredLegacy source lookup
OncoSil Medical: Is Medtech Comeback Finally Here?
- Published
- 22 Jun 2026 16:35
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
22
2026
KalkineArchivedLegacy headline · tone unscoredLegacy source lookup
OncoSil Medical (ASX:OSL): Cancer-Treatment Stock Jumps as Biotech Traders Return
- Published
- 22 Jun 2026 11:44
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
It measures news already published. It is not a forecast, recommendation or price target.